Brian Jones has extensive experience in the field of hard capsules, both in their manufacture and usage. He has visited pharmaceutical companies in the US, Europe, Africa and Asia to give lectures and to assist in problem solving for this particular dosage form. He has been involved with hard capsules and their use and performance in dry powder inhalers since their introduction to the market in the 1960s. Mr Jones has Bachelor’s and Master’s degrees in Pharmacy from the University of Wales and is a Fellow of the Royal Pharmaceutical Society of Great Britain. He is an honorary senior lecturer in the Welsh School of Pharmacy and Pharmaceutical Sciences, Cardiff University, UK.
Brian Jones and Susana Ecenarro Probst discuss the growing interest in using inhaled APIs to treat systemic conditions. Furthermore, they review some of the methods used to engineer molecules to be suitable for DPI capsules and look to the possibility of administering biomolecules via the pulmonary route.